Compare BioNano Genomics Inc (BNGO) vs Emerson Electric Co. (EMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs Emerson Electric Co. — how do they compare? BioNano Genomics Inc trades at $1.15 (market cap $13.20M), while Emerson Electric Co. trades at $137 (market cap $76.22B). The key difference: Emerson Electric Co. is far larger — about 5774.2× BioNano Genomics Inc's market cap, and Emerson Electric Co. pays a 1.63% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | EMR | |
|---|---|---|
Market Cap | $13.20M | $76.22B |
Sector | Health | Industrials |
52-Week High | $4.92 | $161.69 |
52-Week Low | $1.09 | $123.30 |
Enterprise Value | $15.81M | $88.49B |
Dividend Yield | — | 1.63% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bionano Genomics (BNGO) trades at $1.17, down 2.5% today, but maintains a bullish technical signal with strong moving average support. The company shows improving fundamentals with revenue stabilizing around $29M annually and narrowing losses, though it remains unprofitable with a -109.95% net margin. Recent positive developments include debt retirement and growing adoption of optical genome mapping technology.
BNGO presents a high-risk, high-reward opportunity with analyst consensus leaning bullish (57% buy ratings). The stock trades at attractive valuation multiples (P/S 0.31, P/B 0.36) but faces execution risks in achieving profitability. Key catalysts include continued technology adoption and potential margin improvement, while persistent losses and competitive pressures remain concerns.
Emerson Electric (EMR) trades at $135.38, down 2.52% on the day, with a bearish technical signal and mixed earnings history. The stock shows moderate valuation ratios (P/E 31.34, P/S 4.17) and stable profitability (net margin 13.35%). Recent news highlights upcoming Q3 2026 earnings and dividend activity, while cash flow trends indicate operational strength but net outflows.
The outlook is cautiously optimistic with a consensus price target of $157.60 (16.4% upside), supported by analyst buy ratings (51.2%). Key risks include volatile cash flows and competitive pressures in manufacturing electronics. Earnings growth and sector momentum remain catalysts for potential appreciation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About Emerson Electric Co.
Emerson Electric is a multi-industrial conglomerate that operates under two business platforms: automation solutions and commercial and residential solutions. The latter is further subdivided into two operating segments: climate technologies, which sells HVAC and refrigeration products and services as well as tools and home products, which sells tools and compressors, among other products and services. Commercial and residential solutions boasts several household brands, including Copeland and RIDGID. Automation solutions is most known for its process manufacturing solutions, which consists of measurement instrumentation, as well as valves and actuators, among other products and services. Roughly half of the firm's geographic sales take place in the United States.
Read more on EMR →
